Therapeutic coma for status epilepticus
暂无分享,去创建一个
M Brandon Westover | Barbara A Dworetzky | Frank W Drislane | Andrea O Rossetti | Mohamed Faouzi | F. Drislane | M. Westover | B. Dworetzky | A. Rossetti | M. Faouzi | J. Novy | V. Alvarez | Jong Woo Lee | Vincent Alvarez | Jan Novy | Nicola A Marchi | N. Marchi | J. W. Lee
[1] R. Conwit,et al. Intramuscular versus intravenous therapy for prehospital status epilepticus. , 2012, New England Journal of Medicine.
[2] C. Mackenzie,et al. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. , 1987, Journal of chronic diseases.
[3] T. Shireman,et al. Intravenous anesthesia in treatment of nonconvulsive status epilepticus: Characteristics and outcomes , 2015, Epilepsy Research.
[4] Andrea O Rossetti,et al. Management of refractory status epilepticus in adults: still more questions than answers , 2011, The Lancet Neurology.
[5] L. Schultz,et al. Management of Status Epilepticus in Neurological Versus Medical Intensive Care Unit: Does it Matter? , 2013, Neurocritical Care.
[6] R. Rinaldi,et al. Epidemiology of status epilepticus in a rural area of northern Italy: a 2‐year population‐based study , 2005, European journal of neurology.
[7] Jan Claassen,et al. Recommendations on the use of EEG monitoring in critically ill patients: consensus statement from the neurointensive care section of the ESICM , 2013, Intensive Care Medicine.
[8] G. Logroscino,et al. Status Epilepticus Severity Score (STESS) , 2008, Journal of Neurology.
[9] R. Geocadin,et al. Third-line antiepileptic therapy and outcome in status epilepticus: The impact of vasopressor use and prolonged mechanical ventilation* , 2012, Critical care medicine.
[10] S. Cash,et al. Calculating the Risk Benefit Equation for Aggressive Treatment of Non-convulsive Status Epilepticus , 2013, Neurocritical Care.
[11] J. Perlin,et al. Estimating the economic burden of status epilepticus to the health care system , 2005, Seizure.
[12] A. McGonigal,et al. Generalized convulsive status epilepticus management in adults: A cohort study with evaluation of professional practice , 2010, Epilepsia.
[13] B. Burnand,et al. Treatment deviating from guidelines does not influence status epilepticus prognosis , 2013, Journal of Neurology.
[14] W. Hauser,et al. Short‐Term Mortality After a First Episode of Status Epilepticus , 1997, Epilepsia.
[15] S. Marsch,et al. Mortality and recovery from refractory status epilepticus in the intensive care unit: A 7‐year observational study , 2013, Epilepsia.
[16] B. Uthman,et al. A comparison of four treatments for generalized convulsive status epilepticus. Veterans Affairs Status Epilepticus Cooperative Study Group. , 1998, The New England journal of medicine.
[17] Paul M. Vespa,et al. Guidelines for the Evaluation and Management of Status Epilepticus , 2012, Neurocritical Care.
[18] B. Burnand,et al. Status Epilepticus: Impact of Therapeutic Coma on Outcome* , 2015, Critical care medicine.
[19] Eugen Trinka,et al. Unified EEG terminology and criteria for nonconvulsive status epilepticus , 2013, Epilepsia.
[20] E. Wijdicks. The multifaceted care of status epilepticus , 2013, Epilepsia.
[21] D. Lowenstein,et al. Trends in Status Epilepticus-Related Hospitalizations and Mortality: Redefined in US Practice Over Time. , 2015, JAMA neurology.
[22] S. Mayer,et al. Predictors of functional disability and mortality after status epilepticus , 2002, Neurology.
[23] F. Drislane,et al. Practice variability and efficacy of clonazepam, lorazepam, and midazolam in status epilepticus: A multicenter comparison , 2015, Epilepsia.
[24] P. Satishchandra,et al. Management of generalised convulsive status epilepticus (SE): A prospective randomised controlled study of combined treatment with intravenous lorazepam with either phenytoin, sodium valproate or levetiracetam – Pilot study , 2015, Epilepsy Research.
[25] S. Shorvon,et al. Anesthetic drugs in status epilepticus: Risk or rescue? A 6-year cohort study , 2014, Neurology.
[26] H. Prabhakar,et al. Propofol versus thiopental sodium for the treatment of refractory status epilepticus. , 2012, The Cochrane database of systematic reviews.
[27] G. Brophy,et al. Practice Variations in the Management of Status Epilepticus , 2012, Neurocritical Care.
[28] L. Hirsch. Finding the Lesser of Two Evils: Treating Refractory Status Epilepticus , 2015, Epilepsy currents.
[29] G. Logroscino,et al. Refractory status epilepticus: A prospective observational study , 2010, Epilepsia.
[30] J. Britton,et al. Predictors of outcome in refractory status epilepticus. , 2012, JAMA neurology.
[31] B. Burnand,et al. Second‐line status epilepticus treatment: Comparison of phenytoin, valproate, and levetiracetam , 2011, Epilepsia.
[32] M. Aminoff. Do nonconvulsive seizures damage the brain?--No. , 1998, Archives of neurology.
[33] A. Ristić,et al. Etiology of a short-term mortality in the group of 750 patients with 920 episodes of status epilepticus within a period of 10 years (1988–1997) , 2009, Seizure.
[34] S. Shorvon,et al. EFNS guideline on the management of status epilepticus in adults , 2010, European journal of neurology.
[35] C. Kellinghaus,et al. Treatment of status epilepticus in a large community hospital , 2012, Epilepsy & Behavior.
[36] S. Gautam,et al. Duration of refractory status epilepticus and outcome: Loss of prognostic utility after several hours , 2009, Epilepsia.
[37] S. Mayer,et al. High-dose midazolam infusion for refractory status epilepticus , 2014, Neurology.
[38] M. Sperling,et al. Treatment of Status Epilepticus: An International Survey of Experts , 2013, Neurocritical Care.
[39] G. B. Young,et al. Do nonconvulsive seizures damage the brain?--Yes. , 1998, Archives of neurology.